Article
A low-frequency variant in MAPK14 provides mechanistic evidence of a link with myeloperoxidase: a prognostic cardiovascular risk marker.
Journal of the American Heart Association - 27 Aug 2014
Waterworth Dawn M, Li Li, Scott Robert, Warren Liling, Gillson Christopher, Aponte Jennifer, Sarov-Blat Lea, Sprecher Dennis, Dupuis Josée, Reiner Alex, Psaty Bruce M, Tracy Russell P, Lin Honghuang, McPherson Ruth, Chissoe Stephanie, Wareham Nick, Ehm Margaret G
Abstract excerpt
BACKGROUND: Genetics can be used to predict drug effects and generate hypotheses around alternative indications. To support Losmapimod, a p38 mitogen-activated protein kinase inhibitor in development for acute coronary syndrome, we characterized gene variation in MAPK11/14 genes by exome sequencing and follow-up genotyping or imputation in participants well-phenotyped for cardiovascular and metabolic traits....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
